Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE LIABILITY (Details Narrative)

v3.23.3
DERIVATIVE LIABILITY (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Jul. 28, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Gain (Loss) on Sale of Derivatives $ 0    
Derivative Liability, Subject to Master Netting Arrangement, before Offset 36,868 $ 36,868  
Loan Agreement [Member] | K2 HealthVentures LLC [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Secured debt 20,025,456    
Gain (Loss) on Sale of Derivatives $ 0    
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche One [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Secured debt     $ 20,000,000